The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Conor.Bradley@glasgow.ac.uk
School of Cardiovascular & Metabolic Health, Glasgow Cardiovascular Research Centre, BHF Centre of Research Excellence, 126 University Place, G12 8TA
Sidik, N. P. et al. (2024) Invasive endotyping in patients with angina and no obstructive coronary artery disease: a randomized controlled trial. Circulation, 149(1), pp. 7-23. (doi: 10.1161/CIRCULATIONAHA.123.064751) (PMID:37795617)
Bradley, C. P. et al. (2023) The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design. American Heart Journal, 265, pp. 213-224. (doi: 10.1016/j.ahj.2023.08.067) (PMID:37657593)
Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. British Society of Cardiovascular Magnetic Resonance (BSCMR) 17th Annual Congress, Liverpool, UK, 11-12 Oct 2022. (doi: 10.1136/heartjnl-2022-BSCMR.26)
Bradley, C. and Berry, C. (2022) Retinal microvascular function: a tractable biomarker of cardiovascular risk? Cardiovascular Research, 118(16), pp. 3169-3170. (doi: 10.1093/cvr/cvac170) (PMID:36310539)
Bradley, C. and Berry, C. (2022) Definition and epidemiology of coronary microvascular disease. Journal of Nuclear Cardiology, 29(4), pp. 1763-1775. (doi: 10.1007/s12350-022-02974-x) (PMID:35534718)
Sidik, N. P. et al. (2024) Invasive endotyping in patients with angina and no obstructive coronary artery disease: a randomized controlled trial. Circulation, 149(1), pp. 7-23. (doi: 10.1161/CIRCULATIONAHA.123.064751) (PMID:37795617)
Bradley, C. P. et al. (2023) The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design. American Heart Journal, 265, pp. 213-224. (doi: 10.1016/j.ahj.2023.08.067) (PMID:37657593)
Bradley, C. and Berry, C. (2022) Retinal microvascular function: a tractable biomarker of cardiovascular risk? Cardiovascular Research, 118(16), pp. 3169-3170. (doi: 10.1093/cvr/cvac170) (PMID:36310539)
Bradley, C. and Berry, C. (2022) Definition and epidemiology of coronary microvascular disease. Journal of Nuclear Cardiology, 29(4), pp. 1763-1775. (doi: 10.1007/s12350-022-02974-x) (PMID:35534718)
Sykes, R. et al. (2023) Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial. British Society of Cardiovascular Magnetic Resonance (BSCMR) 17th Annual Congress, Liverpool, UK, 11-12 Oct 2022. (doi: 10.1136/heartjnl-2022-BSCMR.26)